Jbtor Plus 50mg/10mg Tablet is a combination medication containing Spironolactone 50mg and Torasemide 10mg, primarily indicated for the management of conditions associated with fluid retention and hypertension. Spironolactone, a potassium-sparing diuretic and aldosterone antagonist, works by inhibiting aldosterone receptors in the distal renal tubules, promoting sodium and water excretion while conserving potassium. Torasemide, a loop diuretic, acts on the thick ascending limb of the loop of Henle to inhibit sodium and chloride reabsorption, resulting in potent diuresis. The synergistic effect of these agents effectively reduces edema in patients with congestive heart failure, liver cirrhosis, and nephrotic syndrome, as well as controlling elevated blood pressure. Jbtor Plus is particularly beneficial in preventing hypokalemia commonly associated with loop diuretics due to the potassium-sparing action of spironolactone. It should be used under medical supervision with regular monitoring of electrolytes, renal function, and blood pressure to avoid potential adverse effects such as hyperkalemia, dehydration, or renal impairment. Contraindications include anuria, acute renal failure, hyperkalemia, and hypersensitivity to either component. This combination offers an effective therapeutic option for fluid management and hypertension control in appropriate clinical settings.